Bar Harbor Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9M Buy
94,999
+751
+0.8% +$162K 1.28% 20
2026
Q1
$20.5M Buy
94,248
+1,156
+1% +$256K 1.2% 22
2025
Q4
$21.3M Buy
93,092
+3,690
+4% +$841K 1.23% 22
2025
Q3
$20.7M Buy
89,402
+3,100
+4% +$631K 1.24% 21
2025
Q2
$16M Buy
86,302
+8,338
+11% +$1.55M 1.03% 28
2025
Q1
$16.3M Sell
77,964
-1,025
-1% -$199K 1.08% 24
2024
Q4
$14M Sell
78,989
-525
-0.7% -$96.5K 0.92% 32
2024
Q3
$15.7M Sell
79,514
-346
-0.4% -$64.6K 1% 28
2024
Q2
$13.7M Sell
79,860
-109
-0.1% -$18.1K 0.91% 31
2024
Q1
$14.6M Buy
79,969
+991
+1% +$171K 0.97% 29
2023
Q4
$12.2M Sell
78,978
-374
-0.5% -$54.5K 0.91% 32
2023
Q3
$11.8M Sell
79,352
-1,093
-1% -$160K 0.94% 32
2023
Q2
$10.8M Sell
80,445
-610
-0.8% -$89.5K 0.83% 37
2023
Q1
$12.9M Sell
81,055
-1,233
-1% -$189K 1.03% 25
2022
Q4
$13.3M Sell
82,288
-1,643
-2% -$252K 1.06% 27
2022
Q3
$11.3M Sell
83,931
-389
-0.5% -$55.8K 0.97% 28
2022
Q2
$12.9M Buy
84,320
+1,574
+2% +$241K 1.03% 24
2022
Q1
$13.4M Sell
82,746
-1,131
-1% -$164K 1.2% 20
2021
Q4
$11.4M Sell
83,877
-2,589
-3% -$306K 0.96% 32
2021
Q3
$9.33M Sell
86,466
-761
-0.9% -$87K 0.87% 35
2021
Q2
$9.82M Sell
87,227
-436
-0.5% -$49.1K 0.91% 34
2021
Q1
$9.49M Sell
87,663
-3,814
-4% -$408K 0.92% 35
2020
Q4
$9.8M Sell
91,477
-464
-0.5% -$44.6K 0.98% 29
2020
Q3
$8.05M Sell
91,941
-644
-0.7% -$60.6K 0.89% 35
2020
Q2
$9.09M Sell
92,585
-8,804
-9% -$775K 1.05% 30
2020
Q1
$7.72M Sell
101,389
-3,960
-4% -$337K 1.04% 27
2019
Q4
$9.33M Sell
105,349
-2,944
-3% -$244K 1.02% 30
2019
Q3
$8.2M Sell
108,293
-8,765
-7% -$601K 0.95% 30
2019
Q2
$8.51M Sell
117,058
-5,452
-4% -$429K 0.99% 27
2019
Q1
$9.87M Sell
122,510
-20,493
-14% -$1.68M 1.18% 28
2018
Q4
$13.2M Sell
143,003
-3,681
-3% -$324K 1.75% 13
2018
Q3
$13.9M Sell
146,684
-3,406
-2% -$323K 1.57% 15
2018
Q2
$13.9M Sell
150,090
-695
-0.5% -$67.9K 1.68% 14
2018
Q1
$14.3M Sell
150,785
-91
-0.1% -$10K 1.75% 12
2017
Q4
$14.6M Buy
150,876
+2,648
+2% +$250K 1.7% 15
2017
Q3
$13.2M Sell
148,228
-1,820
-1% -$139K 1.59% 17
2017
Q2
$10.9M Sell
150,048
-5,506
-4% -$370K 1.31% 19
2017
Q1
$10.1M Sell
155,554
-8,485
-5% -$533K 1.18% 23
2016
Q4
$10.3M Sell
164,039
-1,501
-0.9% -$91.6K 1.13% 24
2016
Q3
$10.4M Buy
165,540
+827
+0.5% +$53.5K 1.18% 23
2016
Q2
$10.2M Buy
164,713
+4,337
+3% +$264K 1.19% 24
2016
Q1
$9.16M Sell
160,376
-383
-0.2% -$21.3K 1.12% 24
2015
Q4
$9.52M Sell
160,759
-698
-0.4% -$40.2K 1.2% 22
2015
Q3
$8.78M Sell
161,457
-1,919
-1% -$125K 1.17% 24
2015
Q2
$11M Sell
163,376
-1,485
-0.9% -$96.9K 1.33% 21
2015
Q1
$9.65M Buy
164,861
+1,237
+0.8% +$74.7K 1.17% 22
2014
Q4
$10.7M Sell
163,624
-1,005
-0.6% -$63.4K 1.34% 21
2014
Q3
$9.51M Sell
164,629
-1,580
-1% -$87.7K 1.22% 21
2014
Q2
$9.38M Sell
166,209
-1,103
-0.7% -$57.9K 1.18% 22
2014
Q1
$8.6M Sell
167,312
-2,654
-2% -$134K 1.11% 23
2013
Q4
$8.98M Sell
169,966
-5,483
-3% -$269K 1.17% 22
2013
Q3
$7.85M Sell
175,449
-7,846
-4% -$348K 1.1% 24
2013
Q2
$7.58M Buy
+183,295
New +$8.02M 1.1% 24

Other funds holding ABBV

Bar Harbor Wealth Management's ABBV Position: Q2 2026 in Review

Bar Harbor Wealth Management increased its AbbVie (ABBV) stake by 0.8% in Q2 2026, buying an estimated $162K and bringing the position to 94,999 shares worth $23.9M. The position accounts for 1.28% of the portfolio, ranked #20.

Bar Harbor Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bar Harbor Wealth Management held 94,999 shares of AbbVie worth $23.9M as of Q2 2026.
  • Bar Harbor Wealth Management bought 751 AbbVie shares in Q2 2026, an estimated $162K.
  • AbbVie made up 1.28% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Bar Harbor Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.